Skin Cancer (Other than Melanoma) New Indication: Neoadjuvant Cemiplimab for Cutaneous Squamous Cell Cancer Ulas D. Bayraktar, MD 2023-06-14
Skin Cancer (Other than Melanoma) New Drug: Retifanlimab in Advanced Merkel Cell Carcinoma Ulas D. Bayraktar, MD 2023-05-20
